2010•PrescriberOpen access

Ulipristal acetate: emergency contraception for up to five days

Steve Chaplin, Sharon Tracey Cameron

Abstract

Abstract Ulipristal acetate (EllaOne) is a new oral emergency contraceptive licensed for up to 120 hours following unprotected intercourse. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse effects and Dr Sharon Cameron discusses its role as an emergency contraceptive. Copyright © 2010 Wiley Interface Ltd

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Ulipristal acetate, Emergency contraception, Medicine, Adverse effect, Gynecology, Family planning, Population, Research methodology